ESTIMATION OF RANOLAZINE AND 11 PHASE-I METABOLITES IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION MASS-SPECTROMETRY WITH SELECTED-ION MONITORING
被引:34
作者:
HERRON, WJ
论文数: 0引用数: 0
h-index: 0
机构:
SYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLANDSYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLAND
HERRON, WJ
[1
]
EADIE, J
论文数: 0引用数: 0
h-index: 0
机构:
SYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLANDSYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLAND
EADIE, J
[1
]
PENMAN, AD
论文数: 0引用数: 0
h-index: 0
机构:
SYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLANDSYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLAND
PENMAN, AD
[1
]
机构:
[1] SYNTEX RES CTR,EDINBURGH EH14 4AP,MIDLOTHIAN,SCOTLAND
The estimation of ranolazine, a novel piperazine derivative, and eleven of its Phase I metabolites has been undertaken by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry (LC-APCI-MS). Plasma samples, taken on day 5 of a multiple-dose study, were extracted by solid-phase extraction (SPE) and analysed, using a gradient HPLC system coupled to the APCI source of a Finnigan MAT TSQ 700 mass spectrometer. Metabolites were analysed in selected-ion monitoring (SIM) mode, using an instrument control language (ICL) procedure. The LC-MS combination allowed resolution of all eleven metabolites, including four hydroxylated metabolites and five unresolved components. The results from the linear regression showed good correlation (r(2) > 0.980) for all the metabolites. Plasma concentrations indicated that three metabolites were present at levels higher than 10% of the parent compound.
机构:
BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543
WARRACK, BM
DIDONATO, GC
论文数: 0引用数: 0
h-index: 0
机构:
BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543
机构:
BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543
WARRACK, BM
DIDONATO, GC
论文数: 0引用数: 0
h-index: 0
机构:
BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,DEPT ANALY RES & DEV,PRINCETON,NJ 08543